UPDATE: Intellipharmaceutics (IPCI) trading halted for regulatory concern
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/18/2024
- Stocks end near flat as investors asses earnings, data
- Netflix crushes subscriber targets but misses on revenue forecast
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- Stocks have priced in much of the 2024 optimism - Wells Fargo
- Wall St closes lower; gold climbs amid economic, geopolitical crosswinds
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
Intellipharmaceutics (IPCI) Comments on Trading Activity; Says Not Aware of Any Corp. Developments
September 22, 2016 4:07 PM EDTIntellipharmaceutics International Inc. (Nasdaq: IPCI) at the request of Investment Industry Regulatory Organization of Canada on behalf of the Toronto Stock Exchange, confirms that as of the date of this news release, they are not aware of any corporate developments that would cause... More
